Immune Health Supplements Market Growth is Driven by COVID-19 Pandemic, Global Sales are Expected to Reach US$ 43.5 billion by 2031

Ads

You May Also Like

Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical ...

MacroGenics Announces Participation in Three Investor Conferences

ROCKVILLE, MD, Oct. 22, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage ...

Novavax Reports First Quarter 2018 Financial Results

GAITHERSBURG, Md., May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its ...